mandar jog
mandar jog
Verified email at
Cited by
Cited by
Building neural representations of habits
MS Jog, Y Kubota, CI Connolly, V Hillegaart, AM Graybiel
Science 286 (5445), 1745-1749, 1999
Fear of falling and postural control in Parkinson's disease
AL Adkin, JS Frank, MS Jog
Movement disorders 18 (5), 496-502, 2003
An update on the diagnosis and treatment of Parkinson disease
P Rizek, N Kumar, MS Jog
Cmaj 188 (16), 1157-1165, 2016
Multichannel electrode and methods of using same
M Jog, S Nikumb
US Patent 7,010,356, 2006
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit
MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ...
JAMA neurology 71 (5), 543-552, 2014
Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study
Huntington Study Group TREND-HD Investigators
Archives of neurology 65 (12), 1582-1589, 2008
Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study
HC Hyson, AM Johnson, MS Jog
Movement disorders: official journal of the Movement Disorder Society 17 (6 …, 2002
Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial
DA Mendonça, K Menezes, MS Jog
Movement disorders: official journal of the Movement Disorder Society 22 (14 …, 2007
Tetrode technology: advances in implantable hardware, neuroimaging, and data analysis techniques
MS Jog, CI Connolly, Y Kubota, DR Iyengar, L Garrido, R Harlan, ...
Journal of neuroscience methods 117 (2), 141-152, 2002
Canadian guidelines on Parkinson's disease
D Grimes, J Gordon, B Snelgrove, I Lim-Carter, E Fon, W Martin, M Wieler, ...
The Canadian journal of neurological sciences. Le journal canadien des …, 2012
An evaluation of sensorimotor integration during locomotion toward a target in Parkinson’s disease
QJ Almeida, JS Frank, EA Roy, ME Jenkins, S Spaulding, AE Patla, ...
Neuroscience 134 (1), 283-293, 2005
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
A McGarry, M McDermott, K Kieburtz, EA de Blieck, F Beal, K Marder, ...
Neurology 88 (2), 152-159, 2017
Chronic acquired hepatocerebral degeneration: case reports and new insights
MS Jog, AE Lang
Movement Disorders: Official Journal of the Movement Disorder Society 10 (6 …, 1995
Dopaminergic modulation of timing control and variability in the gait of Parkinson's disease
QJ Almeida, JS Frank, EA Roy, AE Patla, MS Jog
Movement disorders: official journal of the Movement Disorder Society 22 (12 …, 2007
Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: Protocol for a single-centre, randomized, double-blind, placebo-controlled trial
CRA Silveira, J MacKinley, K Coleman, Z Li, E Finger, R Bartha, ...
BMC neurology 19, 1-10, 2019
Method of fabricating a multichannel electrode
M Jog, S Nikumb
US Patent 7,756,588, 2010
Loudness perception and speech intensity control in Parkinson's disease
JP Clark, SG Adams, AD Dykstra, S Moodie, M Jog
Journal of communication disorders 51, 1-12, 2014
Neurological probe and method of using same
S Nikumb, C Dinkel, M Jog
US Patent 7,853,303, 2010
Towards remote monitoring of Parkinson’s disease tremor using wearable motion capture systems
M Delrobaei, S Memar, M Pieterman, TW Stratton, K McIsaac, M Jog
Journal of the neurological sciences 384, 38-45, 2018
Spinal cord stimulation therapy for gait dysfunction in advanced Parkinson's disease patients
O Samotus, A Parrent, M Jog
Movement Disorders 33 (5), 783-792, 2018
The system can't perform the operation now. Try again later.
Articles 1–20